Elevated glutamate and decreased glutamine levels in the cerebrospinal fluid of patients with MELAS syndrome-Reference-Cited by-同舟云学术

Elevated glutamate and decreased glutamine levels in the cerebrospinal fluid of patients with MELAS syndrome

Published:2022-01-28 Issue:6 Volume:269 Page:3238-3248
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Guerrero-Molina María Paz^ORCID,Morales-Conejo Montserrat^ORCID,Delmiro Aitor^ORCID,Morán María^ORCID,Domínguez-González Cristina^ORCID,Arranz-Canales Elena,Ramos-González Ana,Arenas Joaquín^ORCID,Martín Miguel A.^ORCID,González de la Aleja Jesús^ORCID

Funder

Fundación Eugenio Rodríguez Pascual

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-021-10942-7.pdf

Reference43 articles.

1. Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP (1984) Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 16(4):481–488. https://doi.org/10.1002/ana.410160409

2. El-Hattab AW, Adesina AM, Jones J, Scaglia F (2015) MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab 116(1–2):4–12. https://doi.org/10.1016/j.ymgme.2015.06.004

3. Mariotti C, Savarese N, Suomalainen A et al (1995) Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol 242:304–312. https://doi.org/10.1007/BF00878873